Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
MBX Biosciences Inc (NASDAQ: MBX) closed the day trading at $33.82 up 7.03% from the previous closing price of $31.6. In other words, the price has increased by $7.03 from its previous closing price. On the day, 0.55 million shares were traded. MBX stock price reached its highest trading level at $34.165 during the session, while it also had its lowest trading level at $31.73.
Ratios:
For a better understanding of MBX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.95 and its Current Ratio is at 32.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 20 ’25 when Hawryluk P. Kent bought 20,000 shares for $13.64 per share. The transaction valued at 272,790 led to the insider holds 468,277 shares of the business.
Hoerter Steven L. bought 20,000 shares of MBX for $264,984 on Oct 17 ’25. The Director now owns 20,000 shares after completing the transaction at $13.25 per share. On Sep 26 ’25, another insider, Heron Patrick J, who serves as the Director of the company, bought 666,666 shares for $18.00 each. As a result, the insider paid 11,999,988 and bolstered with 5,219,440 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBX now has a Market Capitalization of 1518595968 and an Enterprise Value of 1127545856.
Stock Price History:
The Beta on a monthly basis for MBX is 0.52, which has changed by 0.66273355 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, MBX has reached a high of $32.17, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is 70.53%, while the 200-Day Moving Average is calculated to be 156.48%.
Shares Statistics:
Over the past 3-months, MBX traded about 1.33M shares per day on average, while over the past 10 days, MBX traded about 658230 shares per day. A total of 44.72M shares are outstanding, with a floating share count of 26.48M. Insiders hold about 41.02% of the company’s shares, while institutions hold 68.56% stake in the company. Shares short for MBX as of 1763078400 were 4629382 with a Short Ratio of 3.47, compared to 1760486400 on 3909541. Therefore, it implies a Short% of Shares Outstanding of 4629382 and a Short% of Float of 16.469998999999998.
Earnings Estimates
MBX Biosciences Inc (MBX) is presently subject to a detailed evaluation by 5.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.76, with high estimates of -$0.65 and low estimates of -$0.9.
Analysts are recommending an EPS of between -$2.29 and -$2.82 for the fiscal current year, implying an average EPS of -$2.62. EPS for the following year is -$3.03, with 6.0 analysts recommending between -$2.1 and -$4.58.
